Eric Stonestreet tells Business Insider how he's adapted to life's twists and turns, from being cast in one of the biggest ...

Lilly, meanwhile, has just raised the stakes in the category with its first-in-class combined GLP-1/GIP agonist Mounjaro (tirzepatide), recently approved for diabetes and in late-stage testing in ...